ADmit Therapeutics is a series a startup. 1 investor tracked.
ADmit Therapeutics is a company founded in 2020 headquartered in Spain. Its most recent tracked round is Series A. Brouky records 4 investors associated with the company.
ADmit Therapeutics is a series a startup. 1 investor tracked.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.